葛兰素史克Glaxosmithkline plc (GSK) 2018年年度报告「LSE」.pdf

1、Annual Report 2018ContentsGSK Annual Report 2018Strategic reportGSK at a glance 01Chairmans statement 02CEOs statement 03Financial performance 04Our long-term priorities 07Key performance indicators 08Industry trends 09Stakeholder engagement 11Our business model 12Pharmaceuticals13Vaccines18Consumer

2、 Healthcare 21Trust24Risk management 34Group financial review 37Corporate GovernanceChairmans Governance statement 66Our Board 68Our Corporate Executive Team 71Leadership and effectiveness 72Nominations Committee report 77Accountability79Audit&Risk Committee report 79Relations with stakeholders89Sci

3、ence Committee report91Corporate Responsibility Committee report 92Remuneration reportChairmans annual statement 96Annual report on remuneration 982017 Remuneration policy summary 120Financial statementsDirectors statement of responsibilities 126Independent Auditors report 128Financial statements 14

4、0Notes to the financial statements 144Financial statements of GlaxoSmithKline plc prepared under UK GAAP 219Investor informationQuarterly trend 224Five-year record 229Product development pipeline 235Product,competition and intellectual property 238Principal risks and uncertainties 241Share capital a

5、nd share price 251Dividends253Financial calendar 253Annual General Meeting 2019 254Tax information for shareholders 254Shareholder services and contacts 256US law and regulation 258Group companies 260Glossary of terms 271Cautionary statementSee the inside back cover of this document for the cautiona

6、ry statement regarding forward-looking statements.Non-financial information statementThe following aligns to the non-financial reporting requirements contained in sections 414CA and 414CB of the Companies Act 2006.Description of the business modelGSK at glance 01Our business model 12Social mattersGl